Authors
Loading...
Knockout of DDX6 influences PB assembly and enhances sensitivity to Ara-C in AML, suggesting targeting DDX6 may improve treatment outcomes.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: